The abstract is read at the publisher; the summary is JClub's.
Real-time sensing of culture-medium metabolic byproducts for insulin-secreting and insulin-responsive cell models is mapped, but no approach yet enables continuous, in situ, multi-analyte inference of culture health.
- Why it matters: Glucose-stimulated insulin secretion, insulin sensitivity, and downstream signalling can reflect culture-chemistry artefacts rather than genuine metabolic dysfunction, and endpoint assays miss evolving oxygen, pH, substrates, and byproducts.
- What they did: This narrative review surveys real-time sensor paradigms—electrochemical enzymatic biosensors, optical/luminescence sensors, vibrational spectroscopy with chemometrics, and electrochemical aptamer sensing—while defining how cell type, basal media, and 2D versus 3D culture shape byproduct accumulation and interpretation.
- The result: It identifies diffusion-limited gradients and serum-borne growth factors as dominant constraints and concludes that continuous, in situ, multi-analyte culture-health inference remains an open challenge for these insulin-related in vitro models.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.